Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine-Reference-Cited by-同舟云学术

Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine

Published:2012-03-13 Issue:3 Volume:8 Page:390-397
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Roteli-Martins Cecilia M.,Naud Paulo,De Borba Paola,Teixeira Julio C.,De Carvalho Newton S.,Zahaf Toufik,Sanchez Nervo,Geeraerts Brecht,Descamps Dominique

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.18865

Reference23 articles.

1. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

2. Against which human papillomavirus types shall we vaccinate and screen? the international perspective

3. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

4. Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

5. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006; 24: S3/11–S3/25; PMID: 16949997; DOI: 10.1016/j.vaccine.2006.05.111.

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lineage Replacement and Genetic Changes of Four HR-HPV Types during the Period of Vaccine Coverage: A Six-Year Retrospective Study in Eastern China;Vaccines;2024-04-12

2. Performance evaluation of fully automated cobas® 6800 CMV PCR for the detection and quantification of cytomegalovirus DNA in neonatal urine and saliva, and adult urine, saliva, and vaginal secretion;Journal of Medical Virology;2023-11

3. Vaccine escape challenges virus prevention: The example of two vaccine‐preventable oncogenic viruses;Journal of Medical Virology;2023-11

4. HPV Vaccination;Colposcopy;2023

5. HPV-Impfung;Kolposkopie in der Praxis;2023